Clinical trial
Protected Carotid Artery Stenting in Subjects at High Risk for Carotid…
NCT00402740 · Abbott Medical Devices, Industry · Completed
Key facts
| NCT number | NCT00402740 |
|---|---|
| Title | Protected Carotid Artery Stenting in Subjects at High Risk for Carotid Endarterectomy (CEA) (PROTECT) |
| Official title | Protected Carotid Artery Stenting in Subjects at High Risk for Carotid Endarterectomy (CEA) |
| Acronym | PROTECT |
| Lead sponsor | Abbott Medical Devices, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Carotid Artery Disease |
| Intervention type | Device |
| Interventions | Xact Stent with either Emboshield Pro (Gen 5) or Emboshield (Gen 3) |
| Enrollment | 322 |
| Start date | Nov 1, 2006 |
| Primary completion | Jun 1, 2011 |
| Completion | Oct 1, 2011 |
| First posted | Nov 22, 2006 |
| Last update posted | Jun 20, 2012 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: